Eli Lilly Director Ralph Alvarez Acquires Deferred Stock Units
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filing Alert: ELI LILLY & Co ($LLY) Insider: Alvarez Ralph (Director) Transaction: Acquisition of 10.66 shares at $1,164.89 (~$12.42K total) Type: Grant/Award (Deferred in lieu of cash retainer) Direct Holdings Post-Transaction: 55,838.22 shares
Comprehensive Analysis
Transaction Overview
On September 21, 2026, Ralph Alvarez, a Director of Eli Lilly & Co ($LLY), acquired 10.6591 shares of Common Stock at an implied price of $1,164.89 per share, representing a total transaction value of approximately $12,416.68.
Filing Details & Structure
- Transaction Code: 'A' (Grant, award, or other acquisition pursuant to Rule 16b-3).
- Nature of Transaction: According to footnote 1, the shares were deferred at the election of the reporting person in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan. They will settle in shares of common stock following separation from service.
- Direct Ownership Post-Transaction: 55,838.2192 shares.
- Indirect Ownership: 758 shares held indirectly via Trust.
Market Significance
This transaction is categorized as Low trading significance. It represents routine director compensation election (deferred cash retainer received as equity) rather than an open-market purchase or discretionary liquidity event.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.